Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

89bio Q4 EPS $(0.48) Beats $(0.69) Estimate

89bio (NASDAQ:ETNB) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.69) by 30.43 percent. This is a 63.08 percent increase over losses of $(1.30) per share from the same
byBenzinga Newsdesk
March 10, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

89bio (NASDAQ:ETNB) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.69) by 30.43 percent. This is a 63.08 percent increase over losses of $(1.30) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview: Enfusion

By Benzinga Insights
November 9, 3:10 PM
Enfusion (NYSE:ENFN) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that Enfusion will report an earnings per share (EPS) of $0.02.

ENFN